Bellerophon Therapeutics, Inc. Skyrocketed
Mon, Feb 10, 2020 at 05:41 PM
Bellerophon Therapeutics, Inc. (BLPH:NASDAQ) rocketted at $4, representing a gain of 1335.2%. On Fri 07 Feb 20, BLPH:NASDAQ hit a New 2-Week Low of $0.28. The stock got featured on our News Catalysts scanner on Fri 07 Feb 20 at 12:59 PM in the 'SPLIT' category. From Fri 17 Jan 20, the stock recorded 7.14% Up Days and 6.67% Green Days
About Bellerophon Therapeutics, Inc. (BLPH:NASDAQ)
Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. It develops products that are focused on the treatment of various types of pulmonary hypertension disorder.
Top 10 Gainers:
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 1335.24%
- Precigen, Inc. (XON:NYSE), 293.2%
- Precigen, Inc. (XON:NASDAQ), 293.2%
- Taubman Centers, Inc. (TCO:NYSE), 53.22%
- vTv Therapeutics Inc. (VTVT:NASDAQ), 52.38%
- Youdao, Inc. (DAO:NYSE), 39.48%
- Kezar Life Sciences, Inc. (KZR:NASDAQ), 34.58%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 32%
- Advaxis, Inc. (ADXS:NASDAQ), 28.71%
- Edgewell Personal Care Company (EPC:NYSE), 27.53%